Diagnósticos da América S.A Cash Flow Conversion Efficiency
Diagnósticos da América S.A cash flow conversion efficiency. Based on the latest financial reports, Diagnósticos da América S.A (DASA3) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$434.13 Million ≈ $85.18 Million USD) by net assets (R$7.84 Billion ≈ $1.54 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Diagnósticos da América S.A (2000–2024)
Cash flow conversion efficiency of Diagnósticos da América S.A from 2000 to 2024. This chart illustrates how Diagnósticos da América S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View DASA3 live share price for real-time trading data and today's change.
Diagnósticos da América S.A Cash Flow Conversion Ratio Explained
Diagnósticos da América S.A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Diagnósticos da América S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diagnósticos da América S.A ranked by their cash flow conversion efficiency. Also see Diagnósticos da América S.A market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Catapult Group International Ltd
AU:CAT
|
0.334x |
|
Wuhan Zhongyuan Huadian Sci Tech
SHE:300018
|
0.071x |
|
Tejas Networks Limited
NSE:TEJASNET
|
-0.154x |
|
Vesuvius India Limited
NSE:VESUVIUS
|
0.170x |
|
Daxin Materials Corp
TW:5234
|
0.068x |
|
Svenska Cellulosa Aktiebolaget SCA (publ)
ST:SCA-A
|
0.007x |
|
SP Setia Bhd
KLSE:8664
|
0.017x |
|
LianChuang Electronic Technology Co Ltd
SHE:002036
|
0.002x |
Annual Cash Flow Conversion Efficiency for Diagnósticos da América S.A (2000–2024)
The table below shows the annual cash flow conversion efficiency of Diagnósticos da América S.A from 2000 to 2024. Review Diagnósticos da América S.A (DASA3) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | R$7.94 Billion ≈ $1.56 Billion |
R$27.95 Million ≈ $5.48 Million |
0.004x | +102.68% |
| 2023-12-31 | R$7.33 Billion ≈ $1.44 Billion |
R$-963.62 Million ≈ $-189.08 Million |
-0.131x | -3112.21% |
| 2022-12-31 | R$7.09 Billion ≈ $1.39 Billion |
R$-29.00 Million ≈ $-5.69 Million |
-0.004x | -102.38% |
| 2021-12-31 | R$7.55 Billion ≈ $1.48 Billion |
R$1.30 Billion ≈ $254.73 Million |
0.172x | -20.65% |
| 2020-12-31 | R$3.54 Billion ≈ $693.93 Million |
R$766.50 Million ≈ $150.40 Million |
0.217x | +1.13% |
| 2019-12-31 | R$3.26 Billion ≈ $640.33 Million |
R$699.37 Million ≈ $137.23 Million |
0.214x | +34.22% |
| 2018-12-31 | R$3.32 Billion ≈ $651.72 Million |
R$530.33 Million ≈ $104.06 Million |
0.160x | -18.85% |
| 2017-12-31 | R$3.32 Billion ≈ $651.43 Million |
R$653.24 Million ≈ $128.18 Million |
0.197x | -33.14% |
| 2016-12-31 | R$2.86 Billion ≈ $561.39 Million |
R$841.94 Million ≈ $165.20 Million |
0.294x | +67.76% |
| 2015-12-31 | R$2.79 Billion ≈ $547.44 Million |
R$489.39 Million ≈ $96.03 Million |
0.175x | +5.89% |
| 2014-12-31 | R$2.77 Billion ≈ $543.95 Million |
R$459.22 Million ≈ $90.11 Million |
0.166x | +75.99% |
| 2013-12-31 | R$2.71 Billion ≈ $531.52 Million |
R$254.98 Million ≈ $50.03 Million |
0.094x | -20.94% |
| 2012-12-31 | R$2.61 Billion ≈ $511.58 Million |
R$310.42 Million ≈ $60.91 Million |
0.119x | +22.26% |
| 2011-12-31 | R$2.54 Billion ≈ $498.79 Million |
R$247.55 Million ≈ $48.57 Million |
0.097x | -69.34% |
| 2010-12-31 | R$614.89 Million ≈ $120.65 Million |
R$195.29 Million ≈ $38.32 Million |
0.318x | +82.30% |
| 2009-12-31 | R$553.64 Million ≈ $108.63 Million |
R$96.46 Million ≈ $18.93 Million |
0.174x | -70.00% |
| 2008-12-31 | R$480.51 Million ≈ $94.29 Million |
R$279.04 Million ≈ $54.75 Million |
0.581x | +229.56% |
| 2007-12-31 | R$513.07 Million ≈ $100.67 Million |
R$90.41 Million ≈ $17.74 Million |
0.176x | -37.78% |
| 2006-12-31 | R$469.21 Million ≈ $92.07 Million |
R$132.87 Million ≈ $26.07 Million |
0.283x | -29.94% |
| 2005-12-31 | R$266.33 Million ≈ $52.26 Million |
R$107.65 Million ≈ $21.12 Million |
0.404x | +104.44% |
| 2004-12-31 | R$244.26 Million ≈ $47.93 Million |
R$48.29 Million ≈ $9.48 Million |
0.198x | -57.21% |
| 2003-12-31 | R$134.59 Million ≈ $26.41 Million |
R$62.18 Million ≈ $12.20 Million |
0.462x | +4.72% |
| 2002-12-31 | R$119.74 Million ≈ $23.50 Million |
R$52.83 Million ≈ $10.37 Million |
0.441x | +74.46% |
| 2001-12-31 | R$131.34 Million ≈ $25.77 Million |
R$33.22 Million ≈ $6.52 Million |
0.253x | +1113.50% |
| 2000-12-31 | R$97.55 Million ≈ $19.14 Million |
R$2.03 Million ≈ $398.91K |
0.021x | -- |
About Diagnósticos da América S.A
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care c… Read more